PlainRecalls
LowClass IIITerminated

FDA Drug recall · Reported July 5, 2017

Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8

Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

Recall #
D-0923-2017
Affected scope
14434 cartons
Initiated
April 27, 2017
Verify with FDA Drug →
View my saved recalls

Noven Pharmaceuticals, Inc. recalled Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx… - a low-severity action.

Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx… was recalled by Noven Pharmaceuticals, Inc. in July 5, 2017. Reason: Defective Delivery System: Out of specification for peel force from the release liner specification during st…. Check the official notice for the remedy. Verify recall #D-0923-2017 with the FDA Drug before acting.

The recall

Noven Pharmaceuticals, Inc. issued this low-severity FDA Drug recall-Defective Delivery System: Out of specification for peel force from the release liner specification during st….

Low
severity level
Class III
classification
July 5, 2017
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0923-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,472 drugs & medications recalls on record

05001,0001,5002,000 2006201220152018202120242026 448
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8

Reason for recall

Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Low (Class III)
Status Terminated
Recall number D-0923-2017
Date reported July 5, 2017
Date initiated April 27, 2017
Recalling firm Noven Pharmaceuticals, Inc.
Firm location Miami, FL
Affected scope 14434 cartons
Distribution Nationwide within US

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0923-2017) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8. Recalled by Noven Pharmaceuticals, Inc.. Units affected: 14434 cartons.
Why was this product recalled?
Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 5, 2017. Severity: Low. Recall number: D-0923-2017.
Where was the recalled product distributed?
Distribution: Nationwide within US.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported July 5, 2017. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026